JOINT FILING AGREEMENTJoint Filing Agreement • March 10th, 2014 • Baker Julian • Biological products, (no disgnostic substances)
Contract Type FiledMarch 10th, 2014 Company IndustryIn accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the common stock, $0.001 par value, of Synageva BioPharma Corp. is being filed with the Securities and Exchange Commission on behalf of each of them.